DSIJ Mindshare

PCBL’s stock has delivered a 35.02 per cent return over the past year, significantly outperforming the Nifty 50, which rose by 5.09 per cent during the same period. Over the past three years, PCBL has rewarded investors with multibagger returns of 200 per cent.

The stock traded 7.1 per cent lower, hitting an intraday low of Rs 2,274 on the NSE.

The new extrusion line will enable the production of profiles up to 300 mm in width. Annual capacity has doubled from 12,000 MT to 24,000 MT.

Under the agreement, Akums will receive an upfront payment of EUR 100 million (Rs 880 crore) to fund product development and secure European regulatory approvals for its oral liquid manufacturing facility.

Bharat Global Developers Ltd. mentioned that the company is committed to regulatory compliance, transparency, and corporate governance.